Resources
Plasmid Files

pT7CFE1-NHA-CHis

Vector with an N-terminal HA tag and a C-terminal 6xHis tag, for use in a human in vitro protein expression system.

To see this sequence with restriction sites, features, and translations, please download
 SnapGene or the free  SnapGene Viewer.

pT7CFE1-NHA-CHis.dna
Map and Sequence File:    Download    Open   
Sequence Author:  Thermo Fisher (Pierce)
Download Free Trial Get SnapGene Viewer


PspOMI (72) PvuII (3567) NaeI (3365) NgoMIV (3363) BtgZI (3263) PsiI (3134) PfoI (2845) AatII (2734) ZraI (2732) ScaI (2292) NmeAIII (1960) BpmI (1882) BsaI (1873) ApaI (76) AvrII (110) HindIII (183) PmlI (275) AarI - BfuAI - BspMI (298) Acc65I (400) KpnI (404) PflMI (412) BtgI (492) MscI * (569) XcmI (577) NdeI (579) BstXI (580) BamHI (584) EcoRI (590) EcoRV (598) PacI (606) PstI (615) Eco53kI (619) SacI (621) SalI - SgrDI (623) AccI (624) HincII (625) EagI - NotI (630) AvaI - BsoBI - PaeR7I - PspXI - XhoI (638) BmeT110I (639) BglII (664) PmeI (708) SpeI (713) BlpI (722) BseYI (1223) PspFI (1227) AlwNI (1335) AhdI (1812) pT7CFE1-NHA-CHis 3660 bp
PspOMI  (72)
1 site
G G G C C C C C C G G G
PvuII  (3567)
1 site
C A G C T G G T C G A C
NaeI  (3365)
1 site
G C C G G C C G G C C G

Efficient cleavage requires at least two copies of the NaeI recognition sequence.
NgoMIV  (3363)
1 site
G C C G G C C G G C C G

Efficient cleavage requires at least two copies of the NgoMIV recognition sequence.
BtgZI  (3263)
1 site
G C G A T G ( N ) 10 C G C T A C ( N ) 10 ( N ) 4

Sticky ends from different BtgZI sites may not be compatible.
After cleavage, BtgZI can remain bound to DNA and alter its electrophoretic mobility.
BtgZI is typically used at 60°C, but is 75% active at 37°C.
PsiI  (3134)
1 site
T T A T A A A A T A T T
PfoI  (2845)
1 site
T C C N G G A A G G N C C T

Sticky ends from different PfoI sites may not be compatible.
AatII  (2734)
1 site
G A C G T C C T G C A G
ZraI  (2732)
1 site
G A C G T C C T G C A G
ScaI  (2292)
1 site
A G T A C T T C A T G A
NmeAIII  (1960)
1 site
G C C G A G ( N ) 18-19 N N C G G C T C ( N ) 18-19

Efficient cleavage requires at least two copies of the NmeAIII recognition sequence.
Sticky ends from different NmeAIII sites may not be compatible.
For full activity, add fresh S-adenosylmethionine (SAM).
BpmI  (1882)
1 site
C T G G A G ( N ) 14 N N G A C C T C ( N ) 14

Efficient cleavage requires at least two copies of the BpmI recognition sequence.
Sticky ends from different BpmI sites may not be compatible.
After cleavage, BpmI can remain bound to DNA and alter its electrophoretic mobility.
BpmI quickly loses activity at 37°C.
BsaI  (1873)
1 site
G G T C T C N C C A G A G N ( N ) 4

Sticky ends from different BsaI sites may not be compatible.
BsaI can be used between 37°C and 50°C.
ApaI  (76)
1 site
G G G C C C C C C G G G

ApaI can be used between 25°C and 37°C.
AvrII  (110)
1 site
C C T A G G G G A T C C
HindIII  (183)
1 site
A A G C T T T T C G A A
PmlI  (275)
1 site
C A C G T G G T G C A C

PmlI gradually loses activity when stored at -20°C.
AarI  (298)
1 site
C A C C T G C ( N ) 4 G T G G A C G ( N ) 4 ( N ) 4

Efficient cleavage requires at least two copies of the AarI recognition sequence.
Sticky ends from different AarI sites may not be compatible.
After cleavage, AarI can remain bound to DNA and alter its electrophoretic mobility.
BfuAI  (298)
1 site
A C C T G C ( N ) 4 T G G A C G ( N ) 4 ( N ) 4

Efficient cleavage requires at least two copies of the BfuAI recognition sequence.
Sticky ends from different BfuAI sites may not be compatible.
BfuAI is typically used at 50°C, but is 50% active at 37°C.
BspMI  (298)
1 site
A C C T G C ( N ) 4 T G G A C G ( N ) 4 ( N ) 4

Efficient cleavage requires at least two copies of the BspMI recognition sequence.
Sticky ends from different BspMI sites may not be compatible.
Acc65I  (400)
1 site
G G T A C C C C A T G G
KpnI  (404)
1 site
G G T A C C C C A T G G
PflMI  (412)
1 site
C C A N N N N N T G G G G T N N N N N A C C

Sticky ends from different PflMI sites may not be compatible.
BtgI  (492)
1 site
C C R Y G G G G Y R C C

Sticky ends from different BtgI sites may not be compatible.
MscI  (569)
1 site
T G G C C A A C C G G T
* Blocked by Dcm methylation.
XcmI  (577)
1 site
C C A N N N N N N N N N T G G G G T N N N N N N N N N A C C

The 1-base overhangs produced by XcmI may be hard to ligate.
Sticky ends from different XcmI sites may not be compatible.
NdeI  (579)
1 site
C A T A T G G T A T A C

Prolonged incubation with NdeI may lead to removal of additional nucleotides.
BstXI  (580)
1 site
C C A N N N N N N T G G G G T N N N N N N A C C

Sticky ends from different BstXI sites may not be compatible.
BamHI  (584)
1 site
G G A T C C C C T A G G

After cleavage, BamHI-HF™ (but not the original BamHI) can remain bound to DNA and alter its electrophoretic mobility.
EcoRI  (590)
1 site
G A A T T C C T T A A G
EcoRV  (598)
1 site
G A T A T C C T A T A G

EcoRV is reportedly more prone than its isoschizomer Eco32I to delete a base after cleavage.
PacI  (606)
1 site
T T A A T T A A A A T T A A T T
PstI  (615)
1 site
C T G C A G G A C G T C
Eco53kI  (619)
1 site
G A G C T C C T C G A G
SacI  (621)
1 site
G A G C T C C T C G A G
SalI  (623)
1 site
G T C G A C C A G C T G
SgrDI  (623)
1 site
C G T C G A C G G C A G C T G C
AccI  (624)
1 site
G T M K A C C A K M T G

Efficient cleavage with AccI requires ≥13 bp on each side of the recognition sequence.
Sticky ends from different AccI sites may not be compatible.
HincII  (625)
1 site
G T Y R A C C A R Y T G
EagI  (630)
1 site
C G G C C G G C C G G C
NotI  (630)
1 site
G C G G C C G C C G C C G G C G
AvaI  (638)
1 site
C Y C G R G G R G C Y C

Sticky ends from different AvaI sites may not be compatible.
BsoBI  (638)
1 site
C Y C G R G G R G C Y C

Sticky ends from different BsoBI sites may not be compatible.
BsoBI is typically used at 37°C, but can be used at temperatures up to 65°C.
PaeR7I  (638)
1 site
C T C G A G G A G C T C

PaeR7I does not recognize the sequence CTCTCGAG.
PspXI  (638)
1 site
V C T C G A G B B G A G C T C V
XhoI  (638)
1 site
C T C G A G G A G C T C
BmeT110I  (639)
1 site
C Y C G R G G R G C Y C
BglII  (664)
1 site
A G A T C T T C T A G A
PmeI  (708)
1 site
G T T T A A A C C A A A T T T G
SpeI  (713)
1 site
A C T A G T T G A T C A
BlpI  (722)
1 site
G C T N A G C C G A N T C G

Sticky ends from different BlpI sites may not be compatible.
BseYI  (1223)
1 site
C C C A G C G G G T C G

After cleavage, BseYI can remain bound to DNA and alter its electrophoretic mobility.
PspFI  (1227)
1 site
C C C A G C G G G T C G
AlwNI  (1335)
1 site
C A G N N N C T G G T C N N N G A C

Sticky ends from different AlwNI sites may not be compatible.
AhdI  (1812)
1 site
G A C N N N N N G T C C T G N N N N N C A G

The 1-base overhangs produced by AhdI may be hard to ligate.
Sticky ends from different AhdI sites may not be compatible.
AmpR
1739 .. 2599  =  861 bp
286 amino acids  =  31.6 kDa
   Segment 2:  
   1739 .. 2530  =  792 bp
   263 amino acids  =  28.9 kDa
Product: β-lactamase
confers resistance to ampicillin, carbenicillin, and related antibiotics
AmpR
1739 .. 2599  =  861 bp
286 amino acids  =  31.6 kDa
   Segment 1:  signal sequence  
   2531 .. 2599  =  69 bp
   23 amino acids  =  2.6 kDa
Product: β-lactamase
confers resistance to ampicillin, carbenicillin, and related antibiotics
AmpR
1739 .. 2599  =  861 bp
286 amino acids  =  31.6 kDa
2 segments
Product: β-lactamase
confers resistance to ampicillin, carbenicillin, and related antibiotics
ori
980 .. 1568  =  589 bp
high-copy-number ColE1/pMB1/pBR322/pUC origin of replication
ori
980 .. 1568  =  589 bp
high-copy-number ColE1/pMB1/pBR322/pUC origin of replication
IRES
70 .. 531  =  462 bp
internal ribosome entry site (IRES) of the encephalomyocarditis virus (EMCV)
IRES
70 .. 531  =  462 bp
internal ribosome entry site (IRES) of the encephalomyocarditis virus (EMCV)
f1 ori
3038 .. 3493  =  456 bp
f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis
f1 ori
3038 .. 3493  =  456 bp
f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis
AmpR promoter
2600 .. 2704  =  105 bp
AmpR promoter
2600 .. 2704  =  105 bp
MCS
567 .. 643  =  77 bp
multiple cloning site
MCS
567 .. 643  =  77 bp
multiple cloning site
T7 terminator
733 .. 780  =  48 bp
transcription terminator for bacteriophage T7 RNA polymerase
T7 terminator
733 .. 780  =  48 bp
transcription terminator for bacteriophage T7 RNA polymerase
poly(A)
675 .. 704  =  30 bp
poly(A)
675 .. 704  =  30 bp
HA
539 .. 565  =  27 bp
9 amino acids  =  1.1 kDa
Product: HA (human influenza hemagglutinin) epitope tag
HA
539 .. 565  =  27 bp
9 amino acids  =  1.1 kDa
Product: HA (human influenza hemagglutinin) epitope tag
T7 promoter
1 .. 19  =  19 bp
promoter for bacteriophage T7 RNA polymerase
T7 promoter
1 .. 19  =  19 bp
promoter for bacteriophage T7 RNA polymerase
6xHis
644 .. 661  =  18 bp
6 amino acids  =  840.9 Da
Product: 6xHis affinity tag
6xHis
644 .. 661  =  18 bp
6 amino acids  =  840.9 Da
Product: 6xHis affinity tag
ATG
533 .. 535  =  3 bp
1 amino acid  =  149.2 Da
Product: start codon
ATG
533 .. 535  =  3 bp
1 amino acid  =  149.2 Da
Product: start codon
ORF:  1869 .. 2135  =  267 bp
ORF:  88 amino acids  =  9.2 kDa
ORF:  1739 .. 2599  =  861 bp
ORF:  286 amino acids  =  31.6 kDa
Try SnapGene and create your own beautiful maps

Individual Sequences & Maps

SnapGene offers the fastest and easiest way to plan, visualize, and document your molecular biology procedures.

Priced accessibly so that everyone in your lab can have a license.

Learn More...

SnapGene Viewer is a versatile tool for creating and sharing richly annotated sequence files. It opens many common file formats.

Free! Because there should be no barriers to seeing your data.

Learn More...

The map, notes, and annotations on this page and in the sequence/map file are copyrighted material. This material may be used without restriction by academic, nonprofit, and governmental entities, except that the source must be cited as "www.snapgene.com/resources". Commercial entities must contact GSL Biotech LLC for permission and terms of use.

Copyright © 2018 GSL Biotech LLC | Site Map | Privacy | Legal Disclaimers   Subscribe to Our Newsletter